http://www.unboundmedicine.com/medline/ebm/research/methoxypolyethylene_glycol_epoetin_betaUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18846269/full_citation/Methoxypolyethylene_glycol_epoetin_beta_for_the_treatment_of_anemia_associated_with_chronic_kidney_disease_Del Vecchio L, Cavalli A, Locatelli F 
Methoxypolyethylene glycol-epoetin beta for the treatment of anemia associated with chronic kidney disease. [Journal Article]
Drugs Today (Barc) 2008 Aug; 44(8):577-84.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18159030/full_citation/FDA_approves_new_epoetin_product:_Roche_unsure_when_it_can_market_in_United_States_Thompson CA 
FDA approves new epoetin product: Roche unsure when it can market in United States. [News]
Am J Health Syst Pharm 2008 Jan 1; 65(1):10.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18037099/full_citation/Efficacy_of_intravenous_methoxy_polyethylene_glycol_epoetin_beta_administered_every_2_weeks_compared_with_epoetin_administered_3_times_weekly_in_patients_treated_by_hemodialysis_or_peritoneal_dialysis:_a_randomized_trial_Klinger M, Arias M, Vargemezis V, et al. 
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Am J Kidney Dis 2007 Dec; 50(6):989-1000.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17962427/full_citation/Pharmacokinetic_and_pharmacodynamic_properties_of_methoxy_polyethylene_glycol_epoetin_beta_are_unaffected_by_the_site_of_subcutaneous_administration_Fishbane S, Pannier A, Liogier X, et al. 
Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Clin Pharmacol 2007 Nov; 47(11):1390-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles